Yuan Mengqin, Hu Xue, Yao Lichao, Chen Ping, Wang Zheng, Liu Pingji, Xiong Zhiyu, Jiang Yingan, Li Lanjuan
Department of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Centre for Infectious Diseases, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
J Clin Transl Hepatol. 2024 Feb 28;12(2):123-133. doi: 10.14218/JCTH.2023.00259. Epub 2023 Nov 30.
Accumulating evidence highlights the association between the gut microbiota and liver cirrhosis. However, the role of the gut microbiota in liver cirrhosis remains unclear.
We first assessed the differences in the composition of the bacterial community between CCl4-induced liver cirrhosis and control mice using 16S rRNA sequencing. We then performed a two-sample Mendelian randomization (MR) analysis to reveal the underlying causal relationship between the gut microbiota and liver cirrhosis. Causal relationships were analyzed using primary inverse variance weighting (IVW) and other supplemental MR methods. Furthermore, fecal samples from liver cirrhosis patients and healthy controls were collected to validate the results of the MR analysis.
Analysis of 16S rRNA sequencing indicated significant differences in gut microbiota composition between the cirrhosis and control groups. IVW analyses suggested that Alphaproteobacteria, Bacillales, NB1n, Rhodospirillales, , , and were positively correlated with the risk of liver cirrhosis, whereas , , , and displayed the opposite effects. However, the weighted median and MR-PRESSO estimates further showed that only and presented stable negative associations with liver cirrhosis. No significant heterogeneity or horizontal pleiotropy was observed in the sensitivity analysis. Furthermore, the result of 16S rRNA sequencing also showed that healthy controls had a higher relative abundance of and than liver cirrhosis patients.
Our study provides new causal evidence for the link between gut microbiota and liver cirrhosis, which may contribute to the discovery of novel strategies to prevent liver cirrhosis.
越来越多的证据凸显了肠道微生物群与肝硬化之间的关联。然而,肠道微生物群在肝硬化中的作用仍不明确。
我们首先使用16S rRNA测序评估四氯化碳诱导的肝硬化小鼠和对照小鼠之间细菌群落组成的差异。然后我们进行了两样本孟德尔随机化(MR)分析,以揭示肠道微生物群与肝硬化之间潜在的因果关系。使用主要逆方差加权(IVW)和其他补充MR方法分析因果关系。此外,收集肝硬化患者和健康对照的粪便样本以验证MR分析的结果。
16S rRNA测序分析表明,肝硬化组和对照组之间的肠道微生物群组成存在显著差异。IVW分析表明,α-变形菌纲、芽孢杆菌目、NB1n、红螺菌目以及(此处原文缺失部分内容)与肝硬化风险呈正相关,而(此处原文缺失部分内容)则表现出相反的作用。然而,加权中位数和MR-PRESSO估计进一步表明,只有(此处原文缺失部分内容)与肝硬化呈现稳定的负相关。在敏感性分析中未观察到显著的异质性或水平多效性。此外,16S rRNA测序结果还表明,健康对照中(此处原文缺失部分内容)的相对丰度高于肝硬化患者。
我们的研究为肠道微生物群与肝硬化之间的联系提供了新的因果证据,这可能有助于发现预防肝硬化的新策略。